Italy· 025300029
NORMIX*12 cpr rivestite 200 mg
A rifaximin product containing rifaximina, registered in Italy by ALFASIGMA SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Rifaximina
- Manufacturer
- ALFASIGMA SpA
- Country
- Italy (IT)
- ATC code
- D06AX11
- ATC class
- Rifaximin
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic025300029NORMIX*12 cpr rivestite 200 mgEUR 7.56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifaximin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandTixtellerAlfasigma S.p.A.
- United KingdomNormix 100mg/5ml granules for oral suspensionImported (Italy)
- CzechiaNORMIXAlfasigma S.p.A., Bologna
- FinlandReferoALFASIGMA S.p.A.
- SpainSPIRAXIN 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAlfasigma S.P.A.
- United StatesXIFAXANCardinal Health 107, LLC
- NetherlandsTIXTELLER 550 mg filmomhulde tablettenAlfasigma S.p.A.
- NorwayNormixAlfa Wassermann
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Colidimin, Refero
- Belgium · Targaxan, Tixteller
- Czechia · Normix
- Germany · Rifaxan, Tixteller
- Denmark · Faxinorm, Xifaxan
- Spain · Spiraxin, Tixtar
- Finland · Targaxan, Xifaxan
- France · Tixtar
- United Kingdom (Northern Ireland) · Normicron, Rifaximin
- Greece · Rifacol
- Hungary · Normix, Refero
- Ireland · Rifaximin Alfasigma, Targaxan
- Luxembourg · Refero, Targaxan
- Netherlands · Tixteller, Xifaxan
- Norway · Xifaxan
- Poland · Tixteller, Xifaxan
- Portugal · Refero, Xifaxan
- Romania · Normix, Tixteller
- Sweden · Xifaxan
- Slovakia · Normix, Refero
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/06e1bacd-2f8e-41db-b3c7-c3205dd84cd2 GET /v1/drugs/06e1bacd-2f8e-41db-b3c7-c3205dd84cd2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 7.56,
"source": "aifa",
"currency": "EUR",
"strength": "RIFAXIMINA 200MG 12 UNITA' USO ORALE",
"substance": "Rifaximina",
"equivalence_group": "FDA",
"transparency_flag": null
}See everything about rifaximin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.